IntrinsicIntrinsic
← Scroll for more →

Financial Statements — LXEO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Cash & Equivalents92.8371.7763.0041.0035.4828.9135.01157.02174.98195.06121.4735.45
Short-term Investments----------70.9286.50----------
Total Current Assets217.91200.86188.39127.79140.06105.27126.12159.46177.15198.09124.2938.87
Property, Plant & Equipment1.121.101.141.231.121.051.031.181.211.041.060.98
Total Non-current Assets*36.9949.4980.3016.0536.0120.4220.8214.4114.8615.1215.5115.85
Total Assets254.90250.36268.69143.84176.07125.69146.94173.87192.01213.21139.8154.72
Accounts Payable4.183.344.864.6620.0211.986.428.445.774.303.792.66
Total Current Liabilities15.6914.1916.8117.2731.5930.8222.8526.8218.8821.6317.2423.04
Total Non-current Liabilities*4.144.675.215.746.266.757.257.728.188.639.039.46
Total Liabilities19.8418.8622.0223.0137.8537.5830.1034.5427.0630.2626.2732.50
Retained Earnings(426.20)(400.33)(380.13)(359.21)(338.93)(312.83)(280.17)(254.25)(224.76)(203.52)(181.84)(167.65)
Total Stockholder Equity235.06231.50246.67120.83138.2288.12116.84139.33164.95182.95113.54(162.81)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total Revenue----------------------0.53
Research & Development19.0315.7016.2115.7014.7217.1718.3723.4216.5615.748.2117.25
Selling, General & Admin8.996.636.915.9515.9716.639.028.126.997.556.763.03
Total Operating Expenses28.0222.3323.1221.6530.6933.8127.3831.5423.5523.2914.9720.27
Operating Income(28.02)(22.33)(23.12)(21.65)(30.69)(33.80)(27.38)(31.54)(23.55)(23.29)(14.97)(20.27)
Interest Expense----------------0.040.040.050.05
Pretax Income(25.87)(20.20)(20.63)(20.28)(26.10)(32.66)(25.92)(29.49)(21.24)(21.68)(14.19)(20.11)
Net Income(25.87)(20.20)(20.92)(20.28)(26.10)(32.66)(25.92)(29.49)(21.24)(21.68)(14.19)(20.11)
Basic EPS(0.30)(0.25)0.06(0.33)(0.60)(0.99)(0.79)(0.89)(0.64)(0.77)19.84(12.36)
Diluted EPS(0.30)(0.25)0.06(0.33)(0.60)(0.99)(0.79)(0.89)(0.64)(0.77)19.84(12.36)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating Cash Flow(17.60)(21.14)(20.08)(29.55)(27.22)(21.72)(28.33)(17.81)(20.15)(14.87)(13.98)(45.51)
Capital Expenditures0.010.040.000.290.11--0.000.080.210.190.070.04
Free Cash Flow*(17.60)(21.18)(20.08)(29.84)(27.33)--(28.33)(17.89)(20.36)(15.05)(14.05)(45.56)
Investing Cash Flow14.2627.46(101.69)35.01(39.17)15.60(93.58)(0.08)(0.22)(0.19)(0.07)(0.09)
Financing Cash Flow24.402.45143.770.0572.960.01(0.10)(0.07)0.2988.65100.073.72
← Scroll for more columns →

* Derived from reported values